A detailed history of Delta Asset Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Delta Asset Management LLC holds 37,223 shares of ABBV stock, worth $6.59 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
37,223
Previous 38,425 3.13%
Holding current value
$6.59 Million
Previous $6.59 Million 11.53%
% of portfolio
0.63%
Previous 0.6%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$163.84 - $199.33 $196,935 - $239,594
-1,202 Reduced 3.13%
37,223 $7.35 Million
Q2 2024

Aug 12, 2024

SELL
$154.79 - $180.76 $73,989 - $86,403
-478 Reduced 1.23%
38,425 $6.59 Million
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $129,454 - $147,501
-810 Reduced 2.04%
38,903 $7.08 Million
Q4 2023

Feb 09, 2024

SELL
$137.6 - $154.97 $131,270 - $147,841
-954 Reduced 2.35%
39,713 $6.15 Million
Q3 2023

Nov 09, 2023

BUY
$133.59 - $154.65 $25,382 - $29,383
190 Added 0.47%
40,667 $6.06 Million
Q2 2023

Aug 10, 2023

SELL
$132.51 - $164.9 $20,009 - $24,899
-151 Reduced 0.37%
40,477 $5.45 Million
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $466,656 - $537,424
3,227 Added 8.63%
40,628 $6.47 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $11,479 - $13,767
83 Added 0.22%
37,401 $6.05 Million
Q3 2022

Nov 09, 2022

BUY
$134.21 - $153.93 $43,349 - $49,719
323 Added 0.87%
37,318 $5.01 Million
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $18,165 - $23,094
-132 Reduced 0.36%
36,995 $5.67 Million
Q1 2022

May 12, 2022

BUY
$131.98 - $163.75 $311,472 - $386,450
2,360 Added 6.79%
37,127 $6.02 Million
Q4 2021

Feb 09, 2022

BUY
$107.43 - $135.93 $421,662 - $533,525
3,925 Added 12.73%
34,767 $4.71 Million
Q3 2021

Nov 03, 2021

BUY
$106.4 - $120.78 $326,754 - $370,915
3,071 Added 11.06%
30,842 $3.33 Million
Q2 2021

Aug 02, 2021

BUY
$105.21 - $117.21 $1.17 Million - $1.3 Million
11,119 Added 66.77%
27,771 $3.13 Million
Q1 2021

Apr 28, 2021

BUY
$102.3 - $112.62 $616,357 - $678,535
6,025 Added 56.7%
16,652 $1.8 Million
Q4 2020

Feb 02, 2021

BUY
$80.49 - $108.67 $218,530 - $295,039
2,715 Added 34.31%
10,627 $1.14 Million
Q2 2020

Jul 23, 2020

SELL
$73.37 - $98.18 $16,875 - $22,581
-230 Reduced 2.82%
7,912 $777,000
Q3 2019

Oct 31, 2019

BUY
$62.98 - $75.72 $107,066 - $128,724
1,700 Added 26.39%
8,142 $617,000
Q1 2019

Apr 30, 2019

BUY
$77.14 - $90.79 $198,866 - $234,056
2,578 Added 66.72%
6,442 $519,000
Q4 2018

Feb 08, 2019

BUY
$77.85 - $96.01 $3,892 - $4,800
50 Added 1.31%
3,864 $356,000
Q3 2018

Oct 22, 2018

BUY
$88.91 - $98.84 $44,455 - $49,420
500 Added 15.09%
3,814 $361,000
Q3 2017

Oct 26, 2017

BUY
$69.85 - $89.22 $231,482 - $295,675
3,314
3,314 $294,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Delta Asset Management LLC Portfolio

Follow Delta Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Delta Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Delta Asset Management LLC with notifications on news.